Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Chiasma gains after upsized IPO

    Chiasma Inc. (NASDAQ:CHMA) gained $4 (25%) to $20 in its first day of trading Thursday after it raised $101.8 million through the sale of 6.4 million shares at $16 in an IPO underwritten by Barclays; Cowen; William …

    Published on 7/16/2015
  • FINANCIAL NEWS: Follow-ons: Ultragenyx, NeuroDerm, Synthetic Biologics

    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), NeuroDerm Ltd. (NASDAQ:NDRM) and Synthetic Biologics Inc. (NYSE-M:SYN) raised a combined $370.9 million in follow-on offerings on Thursday.Ultragenyx raised $264 million …

    Published on 7/16/2015
  • FINANCIAL NEWS: Piqur raises CHF18M in series A extension

    Piqur Therapeutics AG (Basel, Switzerland) raised CHF18 million ($19 million) in a second extension of its series A round from new and existing investors. Prior investor Versant Ventures was among the investors; it led …

    Published on 7/16/2015
  • FINANCIAL NEWS: ProNAi rises following $137.7M IPO

    ProNAi Therapeutics Inc. (NASDAQ:DNAI) jumped $13.30 (81%) to $30.80 in its first day of trading Thursday after raising $137.7 million through the sale of 8.1 million shares at $17 in an IPO. The price valued the …

    Published on 7/16/2015
  • FINANCIAL NEWS: Protagonist raises $40M in series C

    Protagonist Therapeutics Inc. (Milpitas, Calif.) raised $40 million in a series C round led by Canaan Partners. New investors Adage Capital Management; RA Capital; and Foresite Capital also participated, as did existing…

    Published on 7/16/2015
  • FINANCIAL NEWS: AnaptysBio raises $40M in series D

    Antibody play AnaptysBio Inc. (San Diego, Calif.) raised $40 million in an oversubscribed series D round. BVF Partners and its affiliates; Cormorant Asset Management; Frazier Healthcare; HBM Healthcare Investments; …

    Published on 7/15/2015
  • FINANCIAL NEWS: DBV, MacroGenics price follow-ons

    DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT) and MacroGenics Inc. (NASDAQ:MGNX) raised a combined $375.2 million in follow-on offerings.DBV raised $244.8 million through the sale of 7.2 million ADSs at $34 in an …

    Published on 7/15/2015
  • FINANCIAL NEWS: Arivale raises $36M in series B

    Arivale Inc. (Seattle, Wash.) raised $36 million in a series B round led by Arch Venture Partners and Polaris Partners. Maveron, which led the company's $3 million series A round in January 2014, also participated. …

    Published on 7/14/2015
  • FINANCIAL NEWS: J&J talks "disciplined" M&A

    Multiple analysts pressed Johnson & Johnson (NYSE:JNJ) about the pharma's M&A strategy during Tuesday's 2Q15 earnings call. "We do feel that there are several significant opportunities, really across each one of our …

    Published on 7/14/2015
  • FINANCIAL NEWS: WuXi fund to raise $250M

    WuXi Healthcare Ventures Fund II plans to raise $250 million, according to an SEC filing. The fund will invest in healthcare companies in the U.S. and China. Wei Li is listed as the fund's general partner director. In …

    Published on 7/14/2015
  • FINANCIAL NEWS: Financial tracks

    Jay Venkatesan joined Alpine BioVentures as a managing partner. Venkatesan was EVP and general manager at Oncothyreon Inc. (NASDAQ:ONTY).

    Published on 7/13/2015
  • FINANCIAL NEWS: LPs go after Burrill

    Burrill Life Sciences Capital Fund III L.P. filed a lawsuit alleging that G. Steven Burrill, Burrill & Co. and members of the firm's management team embezzled more than $17 million from Fund III between 2007 and 2013. …

    Published on 7/13/2015
  • FINANCIAL NEWS: Nuvelution debuts with funding from Clarus, Novo A/S

    Nuvelution Pharma Inc. (San Francisco, Calif.) debuted on Monday with an undisclosed investment from Clarus Ventures and Novo A/S (Hellerup, Denmark). Nuvelution plans to form risk-sharing partnership with biotech and …

    Published on 7/13/2015
  • FINANCIAL NEWS: Financial tracks

    H.C. Wainwright hired Ed Arce as a managing director in equity research. Arce was a senior research analyst in biopharmaceuticals and specialty pharmaceuticals at Roth Capital Partners.

    Published on 7/10/2015
  • FINANCIAL NEWS: Funding round-up: Atara, TherapeuticsMD, ReNeuron

    Atara Biotherapeutics Inc. (NASDAQ:ATRA) and TherapeuticsMD Inc. (NYSE-M:TXMD) raised a combined $210 million in follow-on offerings, while ReNeuron Group plc (LSE:RENE) raised L68.4 million ($106.5 million) in a …

    Published on 7/10/2015
  • FINANCIAL NEWS: 4SC raises EUR 29M

    4SC AG (Xetra:VSC) raised EUR 29 million ($32.1 million) through the sale of 7.3 million shares at EUR 4 in a rights issue with existing shareholders and a private placement with new investors. Existing shareholder …

    Published on 7/9/2015
  • FINANCIAL NEWS: Clovis raises $275M in follow-on

    Clovis Oncology Inc. (NASDAQ:CLVS) raised $275 million through the sale of 3.5 million shares at $78 in a follow-on underwritten by JPMorgan; Credit Suisse; Stifel; and Mizuho Securities. Clovis proposed the offering …

    Published on 7/9/2015
  • FINANCIAL NEWS: Karolinska Development reassesses portfolio value

    Karolinska Development AB (SSE:KDEV) reduced the reported value of its portfolio to SEK679 million ($80.1 million) in 2Q15 from SEK1.4 billion ($165.1 million) in 1Q15 after it changed its method of valuing early stage …

    Published on 7/9/2015
  • FINANCIAL NEWS: Afferent taps crossover funds for $55M series C

    Afferent Pharmaceuticals Inc. (Boston, Mass.) raised $55 million in a series C round led by new investor Fidelity. New investors Jennison Associates; New Leaf Venture Partners; Partner Fund Management; Redmile Group; …

    Published on 7/8/2015
  • FINANCIAL NEWS: Eligo raises EUR 2M for CRISPR-based antibiotics

    Microbiome antibiotics play Eligo Bioscience S.A.S. (Paris, France) raised EUR 2 million ($2.2 million) in a seed financing from sole investor Seventure Partners. The spinout from Massachusetts Institute of Technology …

    Published on 7/8/2015
  • FINANCIAL NEWS: Abingworth names Haines, von Emster managing partners

    Abingworth named Tim Haines and Kurt von Emster joint managing partners. Haines joined Abingworth in 2005 as a partner in the London office. von Emster joined in January as a partner in the Menlo Park, Calif., office; …

    Published on 7/7/2015
  • FINANCIAL NEWS: 23andMe raises $79.1M toward $150M target

    Genomics company 23andMe Inc. (Mountain View, Calif.) has raised $79.1 million of a planned $150 million round of funding, according to an SEC filing. The company declined to comment. In March, 23andMe said it would …

    Published on 7/6/2015
  • FINANCIAL NEWS: Essex Woodlands raises $360.5M toward $750M fund

    Healthcare investment firm Essex Woodlands has raised a total of $360.5 million toward its planned $750 million Essex Woodlands Fund IX, according to an SEC filing. Essex Woodlands said last year it had raised $221.5 …

    Published on 7/6/2015
  • FINANCIAL NEWS: Financial tracks

    Frazier Healthcare hired Tadataka Yamada as a venture partner on its life sciences team and senior advisor to its growth buyout team. Yamada was CMO and CSO at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502).

    Published on 7/6/2015
  • FINANCIAL NEWS: Mousera adds $20M to series A round

    Mousera Inc. (San Mateo, Calif.) disclosed that it raised $20 million in an extension of its series A round. Data Collective led the financing; fellow new investors Dolby Family Ventures and Ame Cloud Ventures also …

    Published on 7/2/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993